Effect of donor/recipient sex on relapse
Donor/recipient sex . | Adjusted hazard ratio* . | 95% CI . | P . |
---|---|---|---|
Female/male | 1 | NA | NA |
Male/female | 1.21 | 0.99-1.48 | .06 |
Female/female | 1.26 | 1.04-1.52 | .02 |
Male/male | 1.38 | 1.17-1.64 | .0002 |
Donor/recipient sex . | Adjusted hazard ratio* . | 95% CI . | P . |
---|---|---|---|
Female/male | 1 | NA | NA |
Male/female | 1.21 | 0.99-1.48 | .06 |
Female/female | 1.26 | 1.04-1.52 | .02 |
Male/male | 1.38 | 1.17-1.64 | .0002 |
NA indicates not applicable.
Adjusted for patient and donor age, GVHD prophylaxis, disease status, conditioning regimen, and patient/donor CMV serostatus.